CD4 and cancer: reported DZP combined with TACE enhanced the immune functional indexes in serum and the number of CD4+/CD8+ T cells and reduced VEGF, TGF-β1 and MMP-2 to ameliorate cancer metastasis and other adverse reactions after TACE (67).